Key result
Diagnosis and optimal duration of growth hormone therapy in children with idiopathic GH deficiency remain hindered by unresolved issues regarding stimulation tests and IGF-1 reference ranges.
Why the study?
Important clinical problems regarding diagnostic accuracy, test reproducibility, and the optimal duration of GH therapy in children with isolated GHD remain unresolved.
Population
Children and adolescents with GH deficiency
Authors
Loading...
Persistent diagnostic uncertainties warrant cautious GH therapy decisions in children; leaves open need for standardized tests and prospective validation.
The paper highlights long-standing unresolved issues in the diagnosis of idiopathic growth hormone deficiency and the optimal duration of growth hormone therapy in children.
Joanna Smyczyńska (2022) conducted a review in Idiopathic growth hormone deficiency. Growth hormone (GH) therapy was evaluated. Diagnosis and optimal duration of growth hormone therapy in children with idiopathic GH deficiency remain hindered by unresolved issues regarding stimulation tests and IGF-1 reference ranges.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: